A prognostic lncRNA signature associated with ribonucleotide reductase predicts overall survival and immune landscape in hepatocellular carcinoma
Introduction Hepatocellular carcinoma (HCC) is a major cause of cancer‐related mortality, and effective prognostic stratification remains urgently needed. Ribonucleotide reductase (RR), consisting mainly of RRM1 and RRM2, plays a critical role in nucleotide metabolism and tumor progression. This study aimed to develop...